Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review

Gian Maria Pacifici Medical School, Department of Translational Research and New Technologies in Medicine and Surgery, Section of Pharmacology, University of Pisa, Pisa, Italy Objective: The objective of this study was to evaluate the extent of renal adverse effects caused by ibuprofen or indometh...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Pacifici GM
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/acc7bd508b4544d4b9ab4538559aea70
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:acc7bd508b4544d4b9ab4538559aea70
record_format dspace
spelling oai:doaj.org-article:acc7bd508b4544d4b9ab4538559aea702021-12-02T07:24:22ZDifferential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review1179-1438https://doaj.org/article/acc7bd508b4544d4b9ab4538559aea702014-07-01T00:00:00Zhttp://www.dovepress.com/differential-renal-adverse-effects-of-ibuprofen-and-indomethacin-in-pr-peer-reviewed-article-CPAAhttps://doaj.org/toc/1179-1438 Gian Maria Pacifici Medical School, Department of Translational Research and New Technologies in Medicine and Surgery, Section of Pharmacology, University of Pisa, Pisa, Italy Objective: The objective of this study was to evaluate the extent of renal adverse effects caused by ibuprofen or indomethacin in order to choose the safer drug to administer to preterm infants. Methods: The following three parameters of renal function were taken into consideration: 1) the urine output; 2) the serum creatinine concentration; and 3) the frequency of oliguria. The bibliographic search was performed using PubMed and Embase databases as search engines. Results: Urine output ranged from 3.5±1.2 to 4.0±1.4 mL/kg/h after ibuprofen treatment, and from 2.8±1.1 to 3.6±1.4 mL/kg/h after indomethacin treatment. The values for ibuprofen are significantly (P<0.05) higher than those for indomethacin. The serum creatinine concentrations ranged from 0.98±0.24 to 1.48±0.2 mg/dL after ibuprofen treatment, and from 1.06±0.24 and 2.03±2.10 mg/dL after indomethacin treatment. The values for ibuprofen are significantly (P<0.05) lower than those for indomethacin. The frequency of oliguria ranged from 1.0% to 9.6% (ibuprofen) and from 14.8% to 40.0% (indomethacin), and was significantly lower following ibuprofen than indomethacin administration. In infants with body weight lower than 1,000 g, oliguria appeared in 5% (ibuprofen) and 40% (indomethacin; P=0.02). Conclusion: Indomethacin is associated with more severe renal adverse effects than ibuprofen. Ibuprofen is less nephrotoxic than indomethacin and should be used to treat patent ductus arteriosus in preterm infants. Immaturity increases the frequency of adverse effects of indomethacin. Keywords: ibuprofen, indomethacin, patent-ductus-arteriosus, renal-side-effectsPacifici GMDove Medical PressarticleTherapeutics. PharmacologyRM1-950ENClinical Pharmacology: Advances and Applications, Vol 2014, Iss default, Pp 111-116 (2014)
institution DOAJ
collection DOAJ
language EN
topic Therapeutics. Pharmacology
RM1-950
spellingShingle Therapeutics. Pharmacology
RM1-950
Pacifici GM
Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
description Gian Maria Pacifici Medical School, Department of Translational Research and New Technologies in Medicine and Surgery, Section of Pharmacology, University of Pisa, Pisa, Italy Objective: The objective of this study was to evaluate the extent of renal adverse effects caused by ibuprofen or indomethacin in order to choose the safer drug to administer to preterm infants. Methods: The following three parameters of renal function were taken into consideration: 1) the urine output; 2) the serum creatinine concentration; and 3) the frequency of oliguria. The bibliographic search was performed using PubMed and Embase databases as search engines. Results: Urine output ranged from 3.5±1.2 to 4.0±1.4 mL/kg/h after ibuprofen treatment, and from 2.8±1.1 to 3.6±1.4 mL/kg/h after indomethacin treatment. The values for ibuprofen are significantly (P<0.05) higher than those for indomethacin. The serum creatinine concentrations ranged from 0.98±0.24 to 1.48±0.2 mg/dL after ibuprofen treatment, and from 1.06±0.24 and 2.03±2.10 mg/dL after indomethacin treatment. The values for ibuprofen are significantly (P<0.05) lower than those for indomethacin. The frequency of oliguria ranged from 1.0% to 9.6% (ibuprofen) and from 14.8% to 40.0% (indomethacin), and was significantly lower following ibuprofen than indomethacin administration. In infants with body weight lower than 1,000 g, oliguria appeared in 5% (ibuprofen) and 40% (indomethacin; P=0.02). Conclusion: Indomethacin is associated with more severe renal adverse effects than ibuprofen. Ibuprofen is less nephrotoxic than indomethacin and should be used to treat patent ductus arteriosus in preterm infants. Immaturity increases the frequency of adverse effects of indomethacin. Keywords: ibuprofen, indomethacin, patent-ductus-arteriosus, renal-side-effects
format article
author Pacifici GM
author_facet Pacifici GM
author_sort Pacifici GM
title Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
title_short Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
title_full Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
title_fullStr Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
title_full_unstemmed Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
title_sort differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/acc7bd508b4544d4b9ab4538559aea70
work_keys_str_mv AT pacificigm differentialrenaladverseeffectsofibuprofenandindomethacininpreterminfantsareview
_version_ 1718399471511928832